1.Comparison of Endoscopic and Histological Findings between Typical and Atypical Celiac Disease in Children.
Pooja SEMWAL ; Raj Kumar GUPTA ; Rahul SHARMA ; Kapil GARG
Pediatric Gastroenterology, Hepatology & Nutrition 2018;21(2):86-92
PURPOSE: Celiac disease is a common non-communicable disease with varied presentations. Purpose of this study was to find the duodeno-endoscopic features in celiac disease and to compare duodeno-endoscopic and histological findings between typical and atypical celiac disease in children. METHODS: Hospital based observational study was conducted at Sir Padampat Mother and Child Health Institute, Jaipur from June 2015 to May 2016. Patients were selected and divided in two groups- typical and atypical celiac disease based upon the presenting symptoms. Upper gastrointestinal endoscopy and duodenal biopsy was performed for serology positive patients. Results were analysed using appropriate statistical test of significance. RESULTS: Out of 101 enrolled patients, 47.5% were male. Age ranged from 1 to 18 years. Study showed that 54.5% were typical and 45.5% were atypical. Patients presenting with atypical symptoms were predominantly of older age group. On endoscopy, scalloping, mosaic pattern, reduced fold height and absent fold height; and in histology, advanced Marsh stage were significantly higher in the typical group. CONCLUSION: Awareness of atypical presentations as well as duodeno-endoscopic features may have considerable practical importance for the diagnosis of celiac disease in children. Scalloping, mosaic pattern, reduced fold height and nodularity are main endoscopic markers of celiac disease in children. Endoscopic markers of duodenal mucosa may be important in early diagnosis of celiac disease, in children subjected to endoscopy for atypical presentations or indication other than suspected celiac disease.
Biopsy
;
Celiac Disease*
;
Child Health
;
Child*
;
Diagnosis
;
Early Diagnosis
;
Endoscopy
;
Endoscopy, Gastrointestinal
;
Humans
;
Male
;
Mothers
;
Mucous Membrane
;
Observational Study
;
Pectinidae
;
Wetlands
2.Aberrant myeloid antigen co-expression is correlated with high percentages of CD34-positive cells among blasts of acute lymphoblastic leukemia patients: an Indian tertiary care center perspective.
Rahul Kumar SHARMA ; Abhishek PUROHIT ; Venkatesan SOMASUNDARAM ; Pravas Chandra MISHRA ; Mrinalini KOTRU ; Ravi RANJAN ; Sunil KUMAR ; Sudha SAZAWAL ; Hara Prasad PATI ; Seema TYAGI ; Renu SAXENA
Blood Research 2014;49(4):241-245
BACKGROUND: Aberrant myeloid antigen (MA) co-expression and high expression of CD34 antigen on the blasts of acute lymphoblastic leukemia (ALL) patients are independently reported to have a role in pathogenesis and prognosis. This study was conducted to determine whether these two parameters are related. METHODS: A total of 204 cases of ALL were included in an analysis of blast immunophenotypic data. CD34 expression was categorized as low when less than 50% of blasts were CD34-positive (CD34low) and as high when 50% or more were CD34-positive (CD34high). RESULTS: Of 204 cases of ALL, 163 and 41 were of B-cell origin (B-ALL) and T-cell origin (T-ALL), respectively. Of all cases, 132 (64.7%) showed co-expression of MA and among these, 101 (76.51%) were CD34high, while the remaining 31 (23.48%) were CD34low. Of 72 cases without MA co-expression, 25 (34.72%) were CD34high and 47 (67.25%) were CD34low. Furthermore, of 163 cases of B-ALL, 111 showed co-expression of MA and 84 of these were CD34high. Of 52 cases of B-ALL without MA expression, 22 were CD34high. Among 41 cases of T-ALL, 21 co-expressed MA, 17 of which were CD34high. Moreover, all 20 cases of T-ALL without co-expression of MA were CD34low. These differences were statistically significant. CONCLUSION: We observed a strong correlation between aberrant MA expression and CD34high expression on the blasts of ALL. We hypothesize that these different patient subsets may represent unique prognostic characteristics.
Antigens, CD34
;
B-Lymphocytes
;
Flow Cytometry
;
Humans
;
Immunophenotyping
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
;
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
;
Prognosis
;
T-Lymphocytes
;
Tertiary Care Centers*